◆英語タイトル:Intraoperative Neuromonitoring (IONM) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
|
| ◆商品コード:IMARC23AR0068
◆発行会社(リサーチ会社):IMARC
◆発行日:2023年3月2日
◆ページ数:145
◆レポート形式:英語 / PDF ◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
|
◆販売価格オプション
(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
❖ レポートの概要 ❖アイマーク社発行の当調査資料によると、2022年33億ドルであった世界の術中神経モニタリング(IONM)市場規模が2028年には54億ドルに達し、予測期間中(2023年-2028年)、年平均7.09%成長すると予測されています。当書は、術中神経モニタリング(IONM)の世界市場について総合的に調査・分析されたレポートです。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品・サービス別(システム、付属品、サービス)分析、ソース別(社内モニタリング、外部委託モニタリング)分析、用途別(脊椎手術、脳神経外科、血管外科、耳鼻咽喉科手術、その他)分析、エンドユーザー別(病院、外来手術センター (ASC))分析、地域別(北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ)分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目がまとめられています。なお、当書に掲載されている企業情報には、Accurate Monitoring LLC、Computational Diagnostics Inc.、inomed Medizintechnik GmbH、Intranerve LLC、Medtronic plc、Natus Medical Incorporated、NeuroMonitoring Technologies Inc.、Neurophysiology Services Asia、Nihon Kohden Corporation、NuVasive Inc.、Specialtycare Incなどが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の術中神経モニタリング(IONM)市場規模:製品・サービス別
- システムの市場規模
- 付属品の市場規模
- サービスの市場規模
・世界の術中神経モニタリング(IONM)市場規模:ソース別
- 社内モニタリングの市場規模
- 外部委託モニタリングの市場規模
・世界の術中神経モニタリング(IONM)市場規模:用途別
- 脊椎手術における市場規模
- 脳神経外科における市場規模
- 血管外科における市場規模
- 耳鼻咽喉科手術における市場規模
- その他用途における市場規模
・世界の術中神経モニタリング(IONM)市場規模:エンドユーザー別
- 病院における市場規模
- 外来手術センター (ASC)における市場規模
・世界の術中神経モニタリング(IONM)市場規模:地域別
- 北米の術中神経モニタリング(IONM)市場規模
- アジア太平洋の術中神経モニタリング(IONM)市場規模
- ヨーロッパの術中神経モニタリング(IONM)市場規模
- 中南米の術中神経モニタリング(IONM)市場規模
- 中東/アフリカの術中神経モニタリング(IONM)市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況 |
The global intraoperative neuromonitoring (IONM) market size reached US$ 3.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.09% during 2023-2028.
An intraoperative neuromonitoring (IONM) system comprises a group of procedures that can detect, monitor, and confirm nerve function and help minimize the odds of neurological problems during or after neurological surgical procedures. It reduces the risks of nerve function being damaged as a result of improper positioning of the patient or any neurophysiologically-relevant nerve structures. An IONM allows surgeons to identify electrophysiologic changes during spine, head or neck surgery, which may be crucial in extending incisions, placing implants, positioning limbs, and performing retraction techniques that can prevent permanent nerve damage. Using targeted neurostimulation, nerve structures can be identified to prevent potential damage, thus allowing surgeons to focus on optimizing interventions while preserving function. Consequently, these systems are extensively used in neuro, ENT, emergency, visceral, cardiothoracic, orthopedic, and vascular surgeries.
Intraoperative Neuromonitoring (IONM) Market Trends:
The market is majorly driven by the augmenting focus on patient safety during complex surgical procedures. This can be attributed to a considerable rise in the prevalence of chronic neurovascular disorders, such as epilepsy, stroke, Parkinson’s disease and Alzheimer’s disease. In addition to this, the escalating demand for minimally invasive and non-invasive surgeries resulting in a higher uptake of advanced intraoperative neuromonitoring devices is propelling the market. Moreover, the growing trend of medical tourism across the globe is also creating lucrative growth opportunities for the market. The market is further driven by the expanding expenditure on advanced healthcare services. Some of the other factors providing an impetus to the market include the paradigm shift towards outsourced monitoring, the increasing geriatric population that is susceptible to developing neurological disorders, favorable government initiatives and reimbursement plans, and extensive research and development (R&D), collaborations, and joint ventures among the key players.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intraoperative neuromonitoring (IONM) market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and services, source type, application and end user.
Breakup by Product and Services:
Systems
Accessories
Services
Breakup by Source Type:
Insourced Monitoring
Outsourced Monitoring
Breakup by Application:
Spinal Surgery
Neurosurgery
Vascular Surgery
ENT Surgery
Orthopedic Surgery
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers (ASCs)
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accurate Monitoring LLC, Computational Diagnostics Inc., inomed Medizintechnik GmbH, Intranerve LLC, Medtronic plc, Natus Medical Incorporated, NeuroMonitoring Technologies Inc., Neurophysiology Services Asia, Nihon Kohden Corporation, NuVasive Inc., Specialtycare Inc. and Technomed.
Key Questions Answered in This Report:
How has the global intraoperative neuromonitoring (IONM) market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global intraoperative neuromonitoring (IONM) market?
What are the key regional markets?
What is the breakup of the market based on the product and services?
What is the breakup of the market based on the source type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global intraoperative neuromonitoring (IONM) market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Intraoperative Neuromonitoring (IONM) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Services
6.1 Systems
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Accessories
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Source Type
7.1 Insourced Monitoring
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Outsourced Monitoring
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Spinal Surgery
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Neurosurgery
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Vascular Surgery
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 ENT Surgery
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Orthopedic Surgery
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgical Centers (ASCs)
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Accurate Monitoring LLC
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Computational Diagnostics Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 inomed Medizintechnik GmbH
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Intranerve LLC
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Medtronic plc
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Natus Medical Incorporated
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 NeuroMonitoring Technologies Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Neurophysiology Services Asia
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Nihon Kohden Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 NuVasive Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Specialtycare Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Technomed
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
❖ 免責事項 ❖http://www.globalresearch.jp/disclaimer